Clinical trial
A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder
NCT04873037 is registered in ClinicalTrials.gov with Corewell Health East as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Overactive Bladder
- Lead sponsor
- Corewell Health East
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 22, 2021
- Completion date
- December 31, 2028
- Enrollment
- 166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
overactive bladder, overactive bladder syndrome, urinary frequency, urinary urgency